DIssecting the Current Treatment Landscape for R/R Follicular Lymphoma

,

OncLive News Network® | <b>Highlighting Key Follicular Lymphoma Data Following ASH 2024</b>

Grzegorz S. Nowakowski, MD, and Samuel Yamshon, MD, break down the current treatment landscape for relapsed/refractory follicular lymphoma.